Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.

[1]  S. Mittal,et al.  Very long-term outcome after initially successful catheter ablation of atrial fibrillation. , 2014, Heart rhythm.

[2]  W. Abhayaratna,et al.  Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. , 2013, JAMA.

[3]  Prashanthan Sanders,et al.  Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.

[4]  Prashanthan Sanders,et al.  The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. , 2012, Archives of internal medicine.

[5]  A. Natale,et al.  Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. , 2012, Journal of the American College of Cardiology.

[6]  P. Sanders,et al.  Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. , 2012, Heart rhythm.

[7]  H. Crijns,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  Dhaval Shah,et al.  Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. , 2012, Journal of the American College of Cardiology.

[9]  Prashanthan Sanders,et al.  Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. , 2012, Heart rhythm.

[10]  Prashanthan Sanders,et al.  Pericardial fat is associated with atrial fibrillation severity and ablation outcome. , 2011, Journal of the American College of Cardiology.

[11]  Y. Ohashi,et al.  Alcohol consumption and risk of atrial fibrillation: a meta-analysis. , 2011, Journal of the American College of Cardiology.

[12]  Matthew Wright,et al.  Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? , 2011, Journal of the American College of Cardiology.

[13]  Andreas Metzner,et al.  Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation: Lessons From a 5-Year Follow-Up , 2010, Circulation.

[14]  Christopher X. Wong,et al.  Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. , 2010, Heart rhythm.

[15]  J. Kalman,et al.  Pulmonary Vein Antral Isolation for Paroxysmal Atrial Fibrillation: Results from Long‐Term Follow‐Up , 2010, Journal of cardiovascular electrophysiology.

[16]  Prashanthan Sanders,et al.  Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. , 2010, Heart rhythm.

[17]  J. Manson,et al.  The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). , 2010, Journal of the American College of Cardiology.

[18]  P. Sanders,et al.  Reverse remodeling of the atria after treatment of chronic stretch in humans: implications for the atrial fibrillation substrate. , 2010, Journal of the American College of Cardiology.

[19]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[20]  M. Nieminen,et al.  In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study , 2010, Blood pressure.

[21]  C. Albert,et al.  Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women , 2009, Circulation.

[22]  Christopher X. Wong,et al.  Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor". , 2009, Journal of the American College of Cardiology.

[23]  F. Sacher,et al.  Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study , 2008, Circulation.

[24]  S. Mittal,et al.  Long‐Term Outcome Following Successful Pulmonary Vein Isolation: Pattern and Prediction of Very Late Recurrence , 2008, Journal of cardiovascular electrophysiology.

[25]  F. Morady,et al.  Body Mass Index, Obstructive Sleep Apnea, and Outcomes of Catheter Ablation of Atrial Fibrillation , 2008, Journal of cardiovascular electrophysiology.

[26]  V. Somers,et al.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[27]  V. Santinelli,et al.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.

[28]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[29]  Atul Verma,et al.  Response of Atrial Fibrillation to Pulmonary Vein Antrum Isolation Is Directly Related to Resumption and Delay of Pulmonary Vein Conduction , 2005, Circulation.

[30]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[31]  S. Ernst,et al.  Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins: Lessons From Double Lasso Technique , 2005, Circulation.

[32]  E. Bernal,et al.  Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.

[33]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[34]  Clifford J Garratt,et al.  Clinical Evaluation of a Policy of Early Repeated Internal Cardioversion for Recurrence of Atrial Fibrillation , 2002, Journal of cardiovascular electrophysiology.

[35]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[36]  J. Camm,et al.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. , 2000, Journal of the American College of Cardiology.

[37]  Yuan Zhang,et al.  Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. , 2013, Heart rhythm.

[38]  I. Katedra.  Commentary to the article: Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006; 48: 2340-7. , 2007 .

[39]  A. Chesson,et al.  The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications , 2007 .

[40]  D. Wyse.  Pulmonary vein isolation was better than antiarrhythmic drugs for symptomatic atrial fibrillation Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005;293:2634-40. , 2006 .

[41]  D. Parish,et al.  Obesity and the risk of new-onset atrial fibrillation. , 2005, JAMA.